Cargando…

Long non-coding ROR promotes the progression of papillary thyroid carcinoma through regulation of the TESC/ALDH1A1/TUBB3/PTEN axis

Papillary thyroidal carcinoma (PTC) is a common endocrine cancer that plagues people across the world. The potential roles of long non-coding RNAs (lncRNAs) in PTC have gained increasing attention. In this study, we aimed to explore whether lncRNA ROR affects the progression of PTC, with the involve...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fan, Yuxia, Fan, Xin, Yan, Hao, Liu, Zheng, Wang, Xiaoming, Yuan, Qingling, Xie, Jie, Lu, Xiubo, Yang, Yang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8850450/ https://www.ncbi.nlm.nih.gov/pubmed/35173149 http://dx.doi.org/10.1038/s41419-021-04210-9

Ejemplares similares

Long non-coding RNA TUG1/microRNA-187-3p/TESC axis modulates progression of pituitary adenoma via regulating the NF-κB signaling pathway
por: Zhang, Rui, et al.
Publicado: (2021)

TESC Promotes TGF-α/EGFR-FOXM1-Mediated Tumor Progression in Cholangiocarcinoma
por: Hsieh, Cheng-Han, et al.
Publicado: (2020)

Preoperative predictors of lateral neck lymph node metastasis in papillary thyroid microcarcinoma
por: Liu, Zheng, et al.
Publicado: (2017)

Validation of the Tunisian Empathy Scale for Children (TESC) in General Population and Children With Autism Spectrum Disorder
por: Ben Youssef, Hela, et al.
Publicado: (2022)

Plasma miR-323 as a Biomarker for Screening Papillary Thyroid Cancer From Healthy Controls
por: Liu, Yang, et al.
Publicado: (2020)

High ALDH1A1 expression correlates with poor survival in papillary thyroid carcinoma
por: Xing, Yue, et al.
Publicado: (2014)

IGFBP5 is an ROR1 ligand promoting glioblastoma invasion via ROR1/HER2-CREB signaling axis
por: Lin, Weiwei, et al.
Publicado: (2023)

Identification of novel TUBB1 variants in patients with macrothrombocytopenia
por: ÇALIŞKANER, Zihni Onur, et al.
Publicado: (2021)

Expanding the genetic spectrum of TUBB1-related thrombocytopenia
por: Palma-Barqueros, Verónica, et al.
Publicado: (2021)

TUBB1 mutations cause thyroid dysgenesis associated with abnormal platelet physiology
por: Stoupa, Athanasia, et al.
Publicado: (2018)

GLUT1 and TUBB4 in Glioblastoma Could be Efficacious Targets
por: Guda, Maheedhara R., et al.
Publicado: (2019)

ROR1 and ROR2 expression in pancreatic cancer
por: Liu, Dongli, et al.
Publicado: (2021)

Repression of GhTUBB1 Reduces Plant Height in Gossypium hirsutum
por: Zhang, Lihua, et al.
Publicado: (2023)

The Th17 immune response is controlled by the Rel–RORγ–RORγT transcriptional axis
por: Ruan, Qingguo, et al.
Publicado: (2011)

LncRNA ROR1-AS1 high expression and its prognostic significance in liver cancer
por: Zhang, Ze, et al.
Publicado: (2020)

ROR1 and ROR2 in Human Malignancies: Potentials for Targeted Therapy
por: Rebagay, Guilly, et al.
Publicado: (2012)

Aldehyde dehydrogenase 1 (ALDH1) immunostaining in axillary lymph node metastases is an independent prognostic factor in ALDH1-positive breast cancer
por: Guan, Xin, et al.
Publicado: (2021)

Targeting ALDH1A1 to induce Necroptosis in Nasopharyngeal Carcinoma
por: Wang, Haihua, et al.
Publicado: (2022)

Evolutionary Divergence in the Catalytic Activity of the CAM-1, ROR1 and ROR2 Kinase Domains
por: Bainbridge, Travis W., et al.
Publicado: (2014)

New insights into the molecular mechanisms of ROR1, ROR2, and PTK7 signaling from the proteomics and pharmacological modulation of ROR1 interactome
por: Raivola, Juuli, et al.
Publicado: (2022)

The miR-195 Axis Regulates Chemoresistance through TUBB and Lung Cancer Progression through BIRC5
por: Yu, Xiaojie, et al.
Publicado: (2019)

Long non-coding RNA ROR decoys gene-specific histone methylation to promote tumorigenesis
por: Fan, Jiayan, et al.
Publicado: (2015)

Discovery and identification of potential biomarkers of papillary thyroid carcinoma
por: Fan, Yuxia, et al.
Publicado: (2009)

TUBB3 and KIF21A in neurodevelopment and disease
por: Puri, Dharmendra, et al.
Publicado: (2023)

Pan-Tissue and -Cancer Analysis of ROR1 and ROR2 Transcript Variants Identify Novel Functional Significance for an Alternative Splice Variant of ROR1
por: John, Miya, et al.
Publicado: (2022)

Association of ALDH1A1-NEK-2 axis in cisplatin resistance in ovarian cancer cells
por: Uddin, Md. Hafiz, et al.
Publicado: (2020)

Chromium (VI)‐induced ALDH1A1/EGF axis promotes lung cancer progression
por: Ge, Xin, et al.
Publicado: (2022)

TCF-1 limits the formation of Tc17 cells via repression of the MAF–RORγt axis
por: Mielke, Lisa A., et al.
Publicado: (2019)

ROR: Nuclear Receptor for Melatonin or Not?
por: Ma, Haozhen, et al.
Publicado: (2021)

Migration and invasion is inhibited by silencing ROR1 and ROR2 in chemoresistant ovarian cancer
por: Henry, C E, et al.
Publicado: (2016)

Erratum to: Long non-coding RNA ROR decoys gene-specific histone methylation to promote tumorigenesis
por: Fan, Jiayan, et al.
Publicado: (2015)

The HOTAIRM1/miR-107/TDG axis regulates papillary thyroid cancer cell proliferation and invasion
por: Li, Dan, et al.
Publicado: (2020)

ROR1: an orphan becomes apparent
por: Kipps, Thomas J.
Publicado: (2022)

Construction and Stable Expression of a Truncated Human Receptor Tyrosine Kinase Ror1 (Ror1-ECD)
por: Forouzesh, Flora, et al.
Publicado: (2012)

High expression level of ROR1 and ROR1-signaling associates with venetoclax resistance in chronic lymphocytic leukemia
por: Ghia, Emanuela M., et al.
Publicado: (2022)

α-MSH regulates intergenic splicing of MC1R and TUBB3 in human melanocytes
por: Dalziel, Martin, et al.
Publicado: (2011)

Chemerin suppresses hepatocellular carcinoma metastasis through CMKLR1-PTEN-Akt axis
por: Li, Jing-Jing, et al.
Publicado: (2018)

lncRNA CADM1-AS1 inhibits cell-cycle progression and invasion via PTEN/AKT/GSK-3β axis in hepatocellular carcinoma
por: Wang, Fan, et al.
Publicado: (2019)

Functional Characterization of MC1R-TUBB3 Intergenic Splice Variants of the Human Melanocortin 1 Receptor
por: Herraiz, Cecilia, et al.
Publicado: (2015)

Correction to: Migration and invasion is inhibited by silencing ROR1 and ROR2 in chemoresistant ovarian cancer
por: Henry, C. E., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_10741nrf2icv5q43ch56a95s1p